Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 5

    1.

    Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes.

    Heinemann L, Nosek L, Kapitza C, Schweitzer MA, Krinelke L.

    Diabetes Care. 2009 Aug;32(8):1437-9. Epub 2009 Jun 1.PMID: 19487635 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

    Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group.

    Diabet Med. 2006 Feb;23(2):141-7.PMID: 16433711 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical performance of a continuous viscometric affinity sensor for glucose.

    Diem P, Kalt L, Haueter U, Krinelke L, Fajfr R, Reihl B, Beyer U.

    Diabetes Technol Ther. 2004 Dec;6(6):790-9.PMID: 15684631 [PubMed - indexed for MEDLINE]Related articles

    4.

    Glutamine affects glutamate metabolism in isolated rat kidney cortex mitochondria.

    Kunz WS, Krinelke L, Gellerich FN.

    Biochim Biophys Acta. 1992 Jun 19;1100(3):329-31.PMID: 1351747 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Characterization of surface fluorescence signals of isolated perfused rat kidney]

    Krinelke L, Kunz WS.

    Biomed Biochim Acta. 1990;49(11):1119-30. German. PMID: 2094217 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...